Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)

Market Cap	5.26B
Revenue (ttm)	1.07B
Net Income (ttm)	-271.33M
Shares Out	538.65M
EPS (ttm)	-0.49
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,506,987
Average Volume	11,209,144
Open	9.47
Previous Close	9.84
Day's Range	9.47 - 10.53
52-Week Range	6.64 - 13.68
Beta	0.64
RSI	62.80
Earnings Date	Aug 27, 2025

About SHE:300497

Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of APIs and pharmaceutical intermediates in China and internationally. The company offers penicillin, carbapenem, and other products, as well as intermediates of antiviral drugs. It also provides contract research, development, and manufacturing services, as well as engages in lithium battery electrolyte additives. The company was formerly known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd and changed its name to Jiangxi Fushine Pharmaceutical ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 1,774
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300497

Financial Performance

In 2024, SHE:300497's revenue was 1.18 billion, a decrease of -26.83% compared to the previous year's 1.61 billion. Losses were -272.10 million, 35.5% more than in 2023.